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Casein kinase-TS (CL-TS), a type-2 casein kinase purified from rat liver cytosol which phosphoryIates se& 
and threonyl residues N-terminal to acidic clusters, is specifically inhibits by ~lyglutamyl peptides which 
are ineffective both on type-l casein kinase and on CAMP-dependent protein kinase. The inhibition is 
competitive toward the protein substrate and non-competitive toward ATP. Among the polyglutamates 
tested (Glu),~ is the most effective (Ki 0.11 FM). (Glu)ro and (Glu)~ are also inhibitors, though less 
powerful than (Gluho, while (Gluh, (Glu)z and free glutamic acid up to 5 mM are ineffective. These resuIts 
disclose the possibility that naturally occurring polypeptides containing long stretches of acidic residues 
may act as physiologic~ inhibitors of type-2 casein kinases. 
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1. INTRODUCTION 
Casein kinases are multifunctional and wide- 
spread protein kinases, preferring casein and 
phosvitin over histones as model substrates, and 
not sensitive either to the cyclic nucleotides or to 
any other known effector of protein kinases 
(review [ 1 I). Consequently the precise physiolog- 
ical role(s) and the regulatory mechanisms of such 
enzymes remain to be elucidated. 
According to their different structure and 
specificity casein kinases can be grouped into two 
different classes: type-l casein kinases, termed also 
S or A, are monomeric enzymes affecting only 
seryl residues of casein and using only ATP as 
phosphate donor; whereas type-2 casein kinases, 
termed also TS or G, are oligomeric enzymes affec- 
ting both Thr and Ser residues of casein and 
capable of utilizing also GTP [l-3]. An additional 
Abbreviations: Ck-TS, casein kinase TS; RII, regulatory 
subunit of CAMP-dependent protein kinase, type II; 
SDS, sodium dodecyl sulfate 
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feature of type-2 casein kinases is their remarkable 
inhibitability by heparin which is almost ineffec- 
tive on type-l casein kinases [4-61. The 
physiological relevance of such an inhibition, 
however, is questionable since heparin and heparin 
like compounds are absent in tissues free of mast 
cells [7] and their translocation across the plasma 
membranes has not yet been proved. 
On the other hand, type-2 casein kinases have 
been shown to require two or more acidic residues 
C terminal to the target residues in model 
substrates [8,9]. SubsequentIy 3, 5 and 6 acidic 
residues have been found close to the C-terminal 
side of the seryi residues affected by type-2 casein 
kinases in troponin T [lo] glycogen synthase [l l] 
and the regulatory subunit of type-2 CAMP- 
dependent protein kinase [ 12,131, respectively, 
which are among the physiological targets of this 
enzyme. Moreover, clusters of more than 10 acidic 
residues characterize the phosphorylation sites of 
some acidic nucleolar proteins [14] affected by a 
protein kinase(s) possibly related to casein kinases. 
These findings prompted us to check whether 
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acidic peptides may act as competitive inhibitors of 
type II casein kinases. The present paper reports 
on the inhibition of rat liver casein kinase TS (Ck- 
TS), a well characterized type-2 casein kinase [2], 
by polymers of glutamic acid. The results show 
that while free glutamic acid as well as the di- and 
tri-peptides (Glu)? and (Glu)3 are ineffective, the 
larger peptides (Glu)s, (Glu)lo and (Glu),~ act as 
specific competitive inhibitors whose efficiency in- 
creases with the length of the polypeptide chain. 
Such a finding discloses the possibility that very 
acidic polypeptides including clusters of Glu 
residues may represent physiological inhibitors of 
type-2 casein kinases. 
2. MATERIALS AND METHODS 
The isolation and purification of rat liver casein 
kinases TS (Ck-TS) and S (CL-S), as well as the 
assay of casein kinase activity and 10% polyacryl- 
amide gel electrophoresis in SDS of radiolabeled 
substrates were either described or quoted in [2]. 
CAMP-dependent protein kinase was isolated 
from rat liver according to [15] and tested on 
histones as in [ 161. Glycogen synthase was purified 
from rat liver as in [17]. A sample of the regulatory 
subunit of type II CAMP-dependent protein kinase 
(RI& prepared from bovine cardiac muscle to 
> 95 070 homogeneity was kindly provided by Pro- 
fessor F. Hofmann (Heidelberg). 
Di- and triglutamic acids were from Serva. Pen- 
taglutamic acid and decaglutamic acid, over 95% 
pure, were prepared by a procedure to be described 
(unpublished). Polyglutamic acid was kindly pro- 
vided by Professor E. Peggion (Padova); its av. M, 
was 10000, corresponding to sequences of 60-70 
residues; it will be also referred to as (Glu)~o. 
3. RESULTS AND DISCUSSION 
Fig.1 shows that a mixture of large polymers of 
glutamic acid, with an av. M, of -10000, drastical- 
ly inhibits CL-TS but neither CL-TS, a type-l 
casein kinase, nor the CAMP-dependent protein 
kinase. Inhibition of Ck-TS occurs with either 
casein or phosvitin as phosphorylatable substrates. 
The concentration of polyglutamate inducing a 
50% inhibition is below 1 PM; i.e., of the same 
order of the Iso values reported for heparin [6], 
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Fig. 1. Specific inhibition of CL-TS by polyglutamate. 
The activities of casein kinases-TS (o--o) and S 
(ti) and of CAMP-dependent protein kinase (H) 
were tested as in section 2. 
which is an extremely powerful inhibitor of type-2 
casein kinases. 
The influence of the length of the polyglutamate 
chain on the inhibitory efficiency is shown in fig.2. 
(Glu)ro and (Glu)s are still inhibitory agents, 
though increasingly less powerful than (Glu)?~. No 
inhibition could be evidenced with either free 
glutamate, (Glu)z or (Glu)3, even increasing the 
concentrations up to 5 mM. 
Fig.3 also shows that the phosphorylation of 
physiological substrates of Ck-TS, like glycogen 
synthase and RII, is efficiently prevented by 
polyglutamate. The autophosphorylation of Ck- 
TS at its P-subunit is inhibited as well (not shown). 
The type of inhibition was investigated by 
kinetic studies, employing as inhibitors either 
b GL”l,O 
1 2 3 4 5 rnM 
Fig.2. Inhibition of Ck-TS by glutamyl peptides of 
increasing length. 
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Fig.3. Phosphorylation of glycogen synthase (left) and 
the regulatory subunit of type II CAMP-dependent 
protein kinase (right) by Ck-TS: inhibition by 
polyglutamate. Phosphorylation was performed by 
replacing casein with either glycogen synthase 
(0.4 mg/ml) or Rrr (0.5 mg/ml). The autoradiographies 
of the 10% polyacrylamide gel electrophoresis n SDS of 
the phosphorylated proteins, are presented. (-) M, 
of the phosphorylated proteins estimated by calibration 
of the SDS gels with proteins of known MI-value [2]. 
(Glu),o or (Glu)ro. In both cases the inhibition was 
competitive with respect to casein and non- 
competitive with respect to ATP (fig.4). Quite 
similar results were obtained using phosvitin in- 
stead of casein as phosphorylatable substrate (not 
shown). A competition between the glutamyl pep- 
tides and the protein substrate was expected con- 
sidering that all the phosphorylation sites of type-2 
casein kinases are characterized by clusters of 
acidic residues which are supposed to be critical for 
the binding to the enzyme [8-131. Rather, the 
negligible inhibitory power of (Glu)~ and (Glu)~ 
might suggest hat the fast phosphorylation of sites 
with only two or three acidic residues [9] could de- 
pend on their inclusion within larger polypeptide 
chains: intact proteins were reported to be prefer- 
red over their proteolytic derivatives by Ck-TS 
[ 181. Thus it will be interesting to see whether short 
polyglutamyl peptides, like (Glu)3 and (Glu)~ can 
0 
Fig.4. Double reciprocal plots for the inhibition of Ck- 
TS by polyglutamates: (A) ATP was 10,~M; (B) casein 
was 2 mg/ml; (Glu)ro and (Glu)io were 1 pM and 
0.42 mM, respectively. 
improve their inhibitory efficiency once included 
into larger non-acidic sequences. 
Several proteins possessing continuous se- 
quences of >40 acidic amino acids and/or an ex- 
tremely high content (up to 50%) of glutamyl 
residues, have been detected in many tissues 
[19,20]. It is conceivable therefore that some of 
them might act as physiological inhibitors of 
type-2 casein kinases. Although the physiological 
concentrations of such putative inhibitors of Ck- 
TS are not known, the concentrations of other in- 
hibitor polypeptides, like the heat-stable inhibitor 
of CAMP-dependent protein kinase and protein 
phosphatase inhibitors 1 and 2, have been 
calculated to be very similar, ranging from 
0.5-1.5 PM [21-231. On the other hand, the Ki of 
(Glu)-lo for CL-T& calculated from the experiment 
of fig.4A, is 0.11 FM, a value quite consistent with 
the hypothesis that structurally related compounds 
might act as inhibitors of type-2 casein kinases in 
vivo . 
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